Call for Papers—AI-Driven Pharmaceutical Innovation: From Molecular Design to Clinical Therapeutic Application

The pharmaceutical sciences are undergoing a transformative shift powered by artificial intelligence, nanomedicine, and pharmacogenomics, accelerating drug discovery, formulation development, and personalized therapeutic strategies. Integrating AI-driven tools with core pharmaceutical research—from molecular drug design to clinical trial optimization—has become pivotal to addressing development bottlenecks and advancing precision medicine.

 

International Journal of Pharmaceutical Sciences and Therapeutic Innovation (IJPSTI) invites high-quality research contributions under the theme “AI-Driven Pharmaceutical Innovation: From Molecular Design to Clinical Therapeutic Application.” This thematic focus aims to highlight interdisciplinary research that explores AI-enabled pharmaceutical development, novel therapeutic technologies, and the translation of lab discoveries into clinical practice.

 

Medicinal chemists, formulation scientists, pharmacologists, clinicians, AI researchers, and regulatory professionals are encouraged to submit original research and review articles that contribute to advancing pharmaceutical science and therapeutic innovation.

 

Key Submission Information

Submission Deadline: 31 July, 2026

Submission Portal: https://journal.bytran-pub.com/index.php/IJPSTI/about/submissions

Editorial Inquiries: editorial_ijpsti@bytran-pub.com

 

International Journal of Pharmaceutical Sciences and Therapeutic Innovation (IJPSTI) Editorial Office

BYTRAN PUBLISHING SERVICE SDN. BHD

Official Website: https://journal.bytran-pub.com/index.php/IJPSTI